Nature Reviews - Cardiology

FEBRUARY 18, 2024

Nature Reviews Cardiology, Published online: 19 February 2024; doi:10.1038/s41569-024-01000-6 Two studies indicate that a reduction in body mass index as a result of either bariatric surgery or pharmacological therapy is associated with a blood pressure-lowering effect.

Blood Pressure 56

Blood Pressure Pharmacology 56

Open Heart

MARCH 25, 2025

Background Current pharmacological approaches for the treatment of orthostatic hypotension (OH) may detrimentally affect supine blood pressure (BP). This side effect is often unacceptable and limits the utility of medical management.

Blood Pressure 52

Blood Pressure Pharmacology Hypertension 52

Heart BMJ

OCTOBER 10, 2024

The frequent concurrence of elevated blood pressure (BP) and type 2 diabetes markedly elevates the risk of cardiovascular disease and mortality. Finally, we outline the role of lifestyle changes and other pharmacological options in attenuating cardiometabolic risks in patients with type 2 diabetes.

Blood Pressure 52

Blood Pressure Diabetes Pharmacology Cardiovascular Disease 52

DAIC

MAY 21, 2024

A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight. Of 102,475 participants, 49.1% were female.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

Hypertension Journal

AUGUST 5, 2024

Despite the widespread availability of both pharmacological and lifestyle therapeutic options, blood pressure control rates across the globe are worsening. In fact, only 23% of individuals with high blood pressure in the United States achieve treatment goals.

Hypertension 77

Hypertension Blood Pressure Pharmacology Risk Factors 77

Frontiers in Cardiovascular Medicine

OCTOBER 15, 2024

Thus, the implementation of evidence-based interventions (EBI) for blood pressure (BP) reduction is pivotal in minimizing this burden. Future EBI should target this underserved/high-burden group to improve disparity gaps within BP reduction via non-pharmacological means.

Blood Pressure 52

Blood Pressure Pharmacology Article Outcomes 52

Hypertension Journal

JANUARY 11, 2024

This connection is complex, related to pathophysiology in blood pressure regulation and the manner by which OH is derived as the difference between 2 blood pressure measurements.

Hypertension 81

Hypertension Blood Pressure Pharmacology Research 81

Dr. Paddy Barrett

APRIL 5, 2024

Primary prevention is the management of the risk factors, e.g. high blood pressure, early in life to prevent complications of the condition, i.e. coronary artery disease. Blood Pressure Control High blood pressure is the risk factor associated with the greatest number of deaths worldwide. N Engl J Med.

Heart Disease 119

Heart Disease Coronary Artery Disease Heart Attack Heart attacks 119

Heart BMJ

JUNE 25, 2024

Despite the existence of well-established risk factors and effective pharmacological treatments for major cardiovascular disease (CVD), these conditions remain among the leading causes of premature death and disability, exerting a substantial burden on health systems worldwide.

Pharmacology 59

Pharmacology Blood Pressure Risk Factors Cardiovascular Disease 59

Journal of Cardiovascular Pharmacology

NOVEMBER 22, 2023

Blood pressure was regularly measured during the experiment. Compared to the RA-treated group, the 6-week CIH resulted in a significant increase in blood pressure, altered heart structure and reduced serum cGMP in WT mice. Blood pressure was regularly measured during the experiment.

Blood Pressure 40

Blood Pressure Cardiac Function Article 40

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Acupuncture, a core technique in the non-pharmacological treatment of Chinese medicine, plays an important role in the treatment of elevated blood pressure. The primary outcome was the efficiency rate of blood pressure reduction, and the secondary outcome was the change in blood pressure after treatment.

Hypertension 64

Hypertension Blood Pressure Public Health Pharmacology 64

Journal of Cardiovascular Pharmacology

OCTOBER 25, 2012

Both drugs lowered mean blood pressure in a dose related manner, while only azelnidipine decreased heart rate. Azelnidipine at 3 mg/kg and amlodipine at 10 mg/kg produced a similar decrease in the rate pressure product, an index for cardiac oxygen consumption.

Pharmacology 40

Pharmacology Blood Pressure Research Article 40

Open Heart

JUNE 29, 2023

A rhythm control strategy was pursued in 82% (n=41) and 20% (n=10) required 3 or more remote pharmacological interventions. Data were uploaded to a digital platform for daily review by the clinical team. Mean heart rate on admission to the virtual ward and discharge was 122±26 and 82±27 bpm respectively.

Atrial Fibrillation 52

Atrial Fibrillation Atrial Flutter COVID-19 Blood Pressure 52

Heart 2023 Conference

FEBRUARY 25, 2023

3) Examine Your Blood Pressure Checking your blood pressure regularly, whether from your physician or indeed the cuff at the drugstore, can keep hypertension from sneaking up on you. When you exfoliate redundant fat and unessential pounds, you reduce the burden on your heart, lungs, blood vessels, and shell.

Blood Pressure 52

Blood Pressure Cholesterol Heart Disease Exercise 52

Frontiers in Cardiovascular Medicine

MARCH 4, 2024

There are numerous effective medications for modifying CAD but new pharmacologic therapies require increasingly large and expensive cardiovascular outcome trials to assess their potential impact on MACE and to obtain regulatory approval. For many disease areas, nearly a half of drugs are approved by the U.S.

Plaque 59

Plaque Coronary Artery Disease Blood Pressure Cardiovascular Disease 59

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Journal of the American Heart Association

MARCH 17, 2025

We investigated whether pharmacological Mchannel activation in the LSG mitigates sympathetic overdrive and arrhythmogenesis in AMI.Methods and ResultsTwentyfour beagles underwent LSG microinjection of either vehicle (n=12) or retigabine (Mchannel activator, 50 M; n=12) 30 minutes before AMI induction.

Ischemia 40

Ischemia Arrhythmia Electrophysiology Blood Pressure 40

DAIC

MAY 16, 2024

Risk factors for PAD include smoking; having Type 1 or Type 2 diabetes, high blood pressure, high cholesterol, chronic kidney disease, atherosclerosis in other parts of the body (such as coronary artery disease); and being age 75 years or older. and Global Data From the American Heart Association.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

The British Journal of Cardiology

NOVEMBER 29, 2023

Blood pressure and lipid profile should be controlled appropriately to guideline targets. Overall, comprehensive assessment and pharmacological modification of risk factors are central to stroke prevention. In patients with diabetes, good glycaemic control can reduce stroke risk.

Strokes 40

Strokes Stroke Risk Factors Blood Pressure 40

Hypertension Journal

FEBRUARY 16, 2024

This steroid hormone regulates salt reabsorption in the kidney and blood pressure. Pharmacological inhibition of T-type channels alone will likely not significantly impact aldosterone production in the long term. The most important stimuli of aldosterone synthesis are the serum concentrations of angiotensin II and potassium.

Blood Pressure 45

Blood Pressure Pharmacology Hypertension 45

Dr. Smith's ECG Blog

OCTOBER 23, 2023

This may be in the strength of the pulse ( or the blood pressure recorded ) — or it may be in one or more waveforms in the ECG recording. This may result from fluctuations in heart rate or in nervous system activity or from pharmacologic treatment.

Tachycardia 131

Tachycardia Cardiac Arrest ICU Blog 131

Circulation

NOVEMBER 11, 2024

hypoxic animals developed PAH with peak RV systolic pressures (RVSP) being significantly higher than normoxic WT and hypoxic WT and hypoxic KO mice. Figure 1) Similar results were noted for RV end-diastolic pressure (Figure 2) and RV wall stress (Figure 3).Conclusions:By

Pulmonary 40

Pulmonary Hypertension Blood Pressure Pharmacology 40

Cardiometabolic Health Congress

JANUARY 3, 2024

It increases the likelihood of developing chronic conditions such as heart disease, diabetes, and high blood pressure. Obesity not only affects an individual’s physical appearance but also poses serious health risks. Tirzepatide is a dual GIP/GLP-1 agonist that activates hormone receptors secreted in the intestines.

Obesity 97

Obesity Diabetes Blood Pressure BMI 97

Cardiometabolic Health Congress

JULY 10, 2024

Bakris was ahead of his time, what we would call prescient in that, although he was a nephrologist, he saw the link between the kidney, high blood pressure, diabetes, and the overall cardiometabolic condition. When I heard of his passing, I felt quite sad.

Hypertension 52

Hypertension Education Blood Pressure Kidney Disease 52

Dr. Smith's ECG Blog

FEBRUARY 8, 2015

Be ready to give nitroprusside if the blood pressure does go unacceptably high [ unopposed alpha in possible cocaine overdose is an overblown concern: see discussion below] Fourth , if it is AV nodal re-entrant tachycardia, sometimes a dose of 18 mg of adenosine is necessary. Only beta-2 blockade (e.g.,

Tachycardia 52

Tachycardia Chest Pain Pharmacology Myocardial Infarction 52

Journal of Cardiovascular Pharmacology

MARCH 4, 2024

Patients should have adequate blood pressure and lipid control to decrease clinical manifestations and symptoms of PAD. Patients should have adequate blood pressure and lipid control to decrease clinical manifestations and symptoms of PAD.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Blood Pressure Risk Factors Nursing 40

Journal of Cardiovascular Pharmacology

NOVEMBER 7, 2024

LH augmented collagen and early markers of kidney injury (blood urea nitrogen-BUN, BUN/Cr). Both doses’ effects were independent of blood pressure and glycemic control. LH augmented collagen and early markers of kidney injury (blood urea nitrogen-BUN, BUN/Cr).

Hypertension 40

Hypertension Blood Pressure Article 40

Wellnest

JUNE 26, 2023

By analyzing the same, it can accurately deduct the person’s age, gender, blood pressure, and smoking status. Using this data; the AI can further predict the patient’s cardiovascular disease risk using optic disks and blood vessels. The deep learning algorithm scans the patient’s rear interior wall of the eye (the fundus).

Cardiovascular Disease 52

Cardiovascular Disease Blood Pressure Patient Care Pharmacology 52

Journal of Cardiovascular Pharmacology

FEBRUARY 26, 2024

The influence of IL-17 inhibition on blood pressure in autoimmune disease patients remains inconclusive. The influence of IL-17 inhibition on blood pressure in autoimmune disease patients remains inconclusive. We obtained integrated data from PubMed, Embase, and ClinicalTrials.gov. Registered by PROSPERO, CRD42016053112).

Hypertension 40

Hypertension Blood Pressure Article 40

Journal of Cardiovascular Pharmacology

JUNE 27, 2012

Results: Compared with 2K1C group, the 2K1C/Irbesartan group and 2K-1C/Emodin plus Irbesartan group had significantly lower systolic blood pressure and local Angiotensin II(P<0.05). The LVMI in each of the three treatment groups was significantly lower than that in the 2K1C group, especially in the combined group.

Hypertension 40

Hypertension Blood Pressure Document Cardiovascular Disease 40

Dr. Smith's ECG Blog

NOVEMBER 19, 2016

The initial blood pressure was 80/palp with a heart rate of 104, respirations 20, oxygen saturations of 94% and a finger stick blood glucose of 268. In addition, the patient received 750 mL of fluid resuscitation with transient improvement of blood pressure.

Ischemia 40

Ischemia Cardiogenic Shock Aortic Stenosis 40

DAIC

JANUARY 23, 2024

1,12,13 While it is important to treat all known risk factors that contribute to ASCVD including high blood pressure, hyperlipidemia, diabetes, and obesity, physicians also need to recognize and treat systemic inflammation in CV disease. Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review.

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Cardiometabolic Health Congress

JULY 25, 2023

So, if a patient is concerned about their weight or blood pressure, treatment needs to be individualized accordingly. [26] Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes—2019.” The Lancet 392.10157 (2018): 1519-1529. American Diabetes Association. “9. Diabetes Care 42.Supplement

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Dr. Smith's ECG Blog

NOVEMBER 28, 2022

Pericardial tamponade is also associated with pulsus paradoxus which is an abnormally large drop in systolic blood pressure greater than 10 mmHg during inspiration. This may be in the strength of the pulse ( or the blood pressure recorded ) — or it may be in one or more waveforms in the ECG recording.

Tachycardia 40

Tachycardia Pericarditis Ultrasound Blood Pressure 40

Dr. Smith's ECG Blog

SEPTEMBER 7, 2020

Blood pressure was normal (109/83). The Differential Diagnosis is: SVT with aberrancy(#) [AVNRT vs. If the rhythm converts and then reverts to tachycardia with either adenosine or electricity, Neither one of those modalities should be attempted until some longer acting pharmacological solution is given. but only when asked.

Tachycardia 52

Tachycardia Heart Disease Dysrhythmia Ablation 52

Cardiometabolic Health Congress

MAY 10, 2024

Results revealed that women are twice as likely to exhibit myocardial ischemia in response to mental stress compared to traditional stressors like exercise or pharmacologic stress. Combining behavioral and pharmacological treatment is most effective. Moreover, women under 50 years old are four times more likely to experience MSIMI.

Coronary Artery Disease 59

Coronary Artery Disease Obesity Chest Pain Ischemia 59

Journal of Cardiovascular Pharmacology

OCTOBER 14, 2024

When co-therapy is unavoidable, early monitoring of renal function, blood volume and blood pressure is excessively crucial. When co-therapy is unavoidable, early monitoring of renal function, blood volume and blood pressure is excessively crucial. However, it is relatively safe in HF patients.

Blood Pressure 40

Blood Pressure Diabetes Hypertension Article 40